By Ben Hirschler and Martinne Geller LONDON (Reuters) - A boom in "nutraceuticals" - food and drinks with potential health benefits - is paving the way for a rush of deals, as food and drug companies compete to dominate a market expected to be worth $280 billion by 2018. "It's only a matter of time before the fight spills over into corporate takeover wars," consultancy KPMG predicted in a report released on Tuesday. Bankers said moving into nutraceuticals was an obvious move for both food and pharma companies given the blurring line between their sectors. "The space is ripe for M&A and I think you are going to see more," added Jeremy Johnson, managing director of North Carolina-based Bourne, which advises on deals.
via Health News Headlines - Yahoo News http://ift.tt/1IBk94g
No comments:
Post a Comment